Regulation of Airway Lactoperoxidase Host Defense
气道乳过氧化物酶宿主防御的调节
基本信息
- 批准号:7386660
- 负责人:
- 金额:$ 33.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-03-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAftercareAgonistAirAlginatesAnti-Bacterial AgentsAntibioticsApicalBacteriaBiological AssayBronchiectasisCell membraneChelating AgentsChemistryChronicClinicalComputer SimulationConsumptionControlled StudyCountCyclic AMPCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDataDefectDepressed moodDiseaseDown-RegulationEF-Hand DomainElementsEnzymesEpithelialEpithelial CellsEpitheliumExhalationFailureFundingGenesGeneticGenetic TranscriptionGrantHost DefenseHumanHydrogen PeroxideHypochloriteIndiumIndividualInfectionInflammationIonophoresKineticsLeadLiquid ChromatographyLiquid substanceMapsMediatingMessenger RNAMetabolismModelingMorphologyNADPH OxidaseOSCN-PathogenesisPatientsPeroxidasePeroxidasesPeroxonitritePhenotypePhysiologicalPlayPrimary Ciliary DyskinesiasProductionProteinsPseudomonas aeruginosaPublishingRaceRateReactive Oxygen SpeciesRecurrenceRegulationRelative (related person)Research PersonnelResistanceReverse Transcriptase Polymerase Chain ReactionRoleSheepSignal TransductionSourceSpectrometry, Mass, Electrospray IonizationSterilityStimulusStressSulfurSuperoxidesSurfaceSystemTaurineTemperatureTestingThapsigarginThiocyanatesTyrosineUp-RegulationVesicleVirusWorkXanthine OxidaseXanthinesairway epitheliumairway hyperresponsivenessairway inflammationairway surface liquidbasecystic fibrosis airwaycystic fibrosis airway epitheliacystic fibrosis patientsdisorder controlenzyme activityfungusgrasphypothiocyanitein vivoinsightlactoperoxidasemRNA ExpressionmRNA Stabilitymucoidneutrophilnovel therapeuticsnuclear runoff assayoxidationprogramspromoterprospectiveresearch studyresponsethiocyanatexanthine
项目摘要
The lactoperoxidase (LPO) system is a significant contributor to airway host defense against bacteria,
viruses and fungi and also is a major consumer of airway H2O2 that in turn is associated with airway
inflammation. A loss of LPO activity may lead to increased airway infection, while any increase in LPO could
have injurious consequences. This application will test the hypothesis that all components of the LPO
system, including LPO enzyme expression and secretion, SCN~ transport across the epithelium and H2O2
production, are coordinately regulated and that an absence of the LPO substrate, SCN~, in cystic fibrosis
(CF) may contribute to pathogenesis. This hypothesis is supported by a computational model of LPO system
activity in airway surface liquid that predicts any unbalance in the components will render the system
inadequate for host defense. The hypothesis and model are supported by preliminary data showing: a) CF
airway epithelia lack normal transport of LPO's substrate, SCN~, to the apical surface that may contribute to
airway infections and inflammation; b) airway epithelia produce H2O2 through Duox, an NADPH oxidase that
may be regulated by intracellular [Ca2+]; c) reactive oxygen species (ROS) increase expression of LPO; and
d) Duox and LPO mRNAs are up-regulated in CF airway epithelia. Specific Aim 1 will address regulation of
Duox H2O2 production in normal and CF airway epithelial cells by changes in [Ca2+]j, cAMP, SCN~ or
proinflammatory and infection related stimuli. Specific Aim 2 will test the hypothesis that defective SCN~
transport in CF airway epithelia results in decreased SCN~ in CF airway secretions in vivo that then may
compromise host defense. SCN~ and peroxidase endproducts will be determined in exhaled breath
condensate using liquid chromatography in tandem with electrospray ionization-mass spectrometry. Specific
Aim 3 will test the hypothesis that ROS and/or SCN" increases LPO mRNA expression in normal and CF
airway epithelia by using turnover studies and nuclear runoff assays. The 5' end of LPO mRNA will be
mapped by RACE and promoter elements in upstream sequences identified. Specific Aim 4 will test the
hypothesis that depressed CF airway SCN" levels contribute to neutrophil-mediated oxidative damage and to
the phenotype of colonizing bacteria observed in CF airways. Lav Summary: These experiments will provide
new information about physiological defects in cystic fibrosis patients that may lead to new therapeutic
approaches to treating this disease.
乳过氧化物酶 (LPO) 系统是气道宿主防御细菌的重要贡献者,
病毒和真菌,也是气道 H2O2 的主要消耗者,而 H2O2 又与气道相关
炎。 LPO 活性的丧失可能会导致气道感染增加,而 LPO 的任何增加都可能导致气道感染增加。
造成有害后果。该应用程序将测试 LPO 的所有组件的假设
系统,包括 LPO 酶的表达和分泌、SCN~ 跨上皮的转运和 H2O2
囊性纤维化中 LPO 底物 SCN~ 的缺失是协调调节的
(CF)可能有助于发病机制。 LPO 系统的计算模型支持了这一假设
气道表面液体的活动预测组件中的任何不平衡都会导致系统
不适合宿主防御。该假设和模型得到初步数据的支持,显示: a) CF
气道上皮缺乏 LPO 底物 SCN~ 到顶端表面的正常运输,这可能有助于
气道感染和炎症; b) 气道上皮通过 Duox(一种 NADPH 氧化酶)产生 H2O2
可能受细胞内[Ca2+]调节; c) 活性氧(ROS)增加LPO的表达;和
d) Duox 和 LPO mRNA 在 CF 气道上皮细胞中上调。具体目标 1 将解决以下问题的监管
通过改变 [Ca2+]j、cAMP、SCN~ 或 正常和 CF 气道上皮细胞产生 Duox H2O2
促炎和感染相关的刺激。具体目标 2 将检验 SCN 缺陷的假设~
CF 气道上皮中的转运导致体内 CF 气道分泌物中的 SCN~ 减少,然后可能
损害宿主防御。 SCN~ 和过氧化物酶终产物将在呼出气中测定
使用液相色谱法与电喷雾电离质谱联用进行冷凝。具体的
目标 3 将检验 ROS 和/或 SCN”增加正常和 CF 中 LPO mRNA 表达的假设
通过使用周转研究和核径流测定来检测气道上皮细胞。 LPO mRNA 的 5' 末端将是
由上游序列中的 RACE 和启动子元件进行定位。具体目标 4 将测试
假设 CF 气道 SCN" 水平降低会导致中性粒细胞介导的氧化损伤,并导致
CF气道中观察到的定植细菌的表型。 Lav 摘要:这些实验将提供
关于囊性纤维化患者生理缺陷的新信息可能会带来新的治疗方法
治疗这种疾病的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory E. Conner其他文献
The Formation of the cAMP / PKA-dependent Annexin 2S 100 A 10 Complex with CFTR Regulates CFTR Channel Function
与 CFTR 形成 cAMP / PKA 依赖性膜联蛋白 2S 100 A 10 复合物调节 CFTR 通道功能
- DOI:
10.1016/s0896-6273(03)00467-7 - 发表时间:
2007 - 期刊:
- 影响因子:3.6
- 作者:
L. Borthwick;J. Mcgaw;Gregory E. Conner;Christopher J. Taylor;V. Gerke;A. Mehta;L. Robson;R. Muimo - 通讯作者:
R. Muimo
NADPH Alters DUOX1 Calcium Responsiveness.
NADPH 改变 DUOX1 钙反应。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:11.4
- 作者:
Gregory E. Conner - 通讯作者:
Gregory E. Conner
P122 EPITHELIAL TLR4 PROMOTES OXIDATIVE STRESS VIA NADPH OXIDASE ACTIVATION AND INDUCES REDOX-SENSITIVE PATHWAYS DURING TUMORIGENESIS
P122 上皮 TLR4 通过 NADPH 氧化酶激活促进氧化应激,并在肿瘤发生过程中诱导氧化还原敏感途径
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:29.4
- 作者:
J. Burgueño;J. Fritsch;Eddy E. González;Yuguang Ban;Ana M. Santander;Nivis Brito;I. Fernández;J. Pignac;E. Fernández;Gregory E. Conner;M. Abreu - 通讯作者:
M. Abreu
Decreased Soluble Adenylyl Cyclase Activity in Cystic Fibrosis Is Related to Defective Apical Bicarbonate Exchange and Affects Ciliary Beat Frequency Regulation*
囊性纤维化中可溶性腺苷酸环化酶活性降低与顶端碳酸氢盐交换缺陷有关,并影响纤毛跳动频率调节*
- DOI:
10.1074/jbc.m110.113621 - 发表时间:
2010-07-16 - 期刊:
- 影响因子:0
- 作者:
A. Schmid;Zoltan Sutto;N. Schmid;Lisa Novak;P. Ivonnet;G. Horvath;Gregory E. Conner;N. Fregien;M. Salathe - 通讯作者:
M. Salathe
The formation of the cAMP/protein kinase A-dependent annexin 2-S100A10 complex with cystic fibrosis conductance regulator protein (CFTR) regulates CFTR channel function.
cAMP/蛋白激酶 A 依赖性膜联蛋白 2-S100A10 复合物与囊性纤维化电导调节蛋白 (CFTR) 的形成可调节 CFTR 通道功能。
- DOI:
10.1091/mbc.e07-02-0126 - 发表时间:
2007-09-01 - 期刊:
- 影响因子:3.3
- 作者:
L. Borthwick;J. Mcgaw;Gregory E. Conner;Christopher J. Taylor;V. Gerke;A. Mehta;L. Robson;R. Muimo - 通讯作者:
R. Muimo
Gregory E. Conner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory E. Conner', 18)}}的其他基金
REGULATION OF AIRWAY LACTOPEROXIDASE HOST DEFENSE
气道乳过氧化物酶宿主防御的调节
- 批准号:
6711667 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
REGULATION OF AIRWAY LACTOPEROXIDASE HOST DEFENSE
气道乳过氧化物酶宿主防御的调节
- 批准号:
6640939 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
REGULATION OF AIRWAY LACTOPEROXIDASE HOST DEFENSE
气道乳过氧化物酶宿主防御的调节
- 批准号:
6530753 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
Regulation of Airway Lactoperoxidase Host Defense
气道乳过氧化物酶宿主防御的调节
- 批准号:
7589771 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
REGULATION OF AIRWAY LACTOPEROXIDASE HOST DEFENSE
气道乳过氧化物酶宿主防御的调节
- 批准号:
6227550 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
Regulation of Airway Lactoperoxidase Host Defense
气道乳过氧化物酶宿主防御的调节
- 批准号:
7195753 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
Regulation of Airway Lactoperoxidase Host Defense
气道乳过氧化物酶宿主防御的调节
- 批准号:
7098647 - 财政年份:2001
- 资助金额:
$ 33.43万 - 项目类别:
FORMATION AND MAINTENANCE OF LYSOSOME STRUCTURE-FUNCTION
溶酶体结构功能的形成和维持
- 批准号:
3289084 - 财政年份:1986
- 资助金额:
$ 33.43万 - 项目类别:
FORMATION AND MAINTENANCE OF LYSOSOME STRUCTURE-FUNCTION
溶酶体结构功能的形成和维持
- 批准号:
3289087 - 财政年份:1986
- 资助金额:
$ 33.43万 - 项目类别:
FORMATION AND MAINTENANCE OF LYSOSOME STRUCTURE-FUNCTION
溶酶体结构功能的形成和维持
- 批准号:
3289080 - 财政年份:1986
- 资助金额:
$ 33.43万 - 项目类别:
相似海外基金
Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer
项目3:绝经前妇女肥胖和子宫内膜增生/癌症的一级预防和子宫保留
- 批准号:
10711638 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection
针对多巴胺介导的社会奖励敏感性来修复社会脱节
- 批准号:
10572245 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
The OUD Cascade of Care and Critical Outcomes: Longitudinal Linkage with Opioid Use
OUD 护理和关键成果级联:与阿片类药物使用的纵向联系
- 批准号:
10741268 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别:
Contributions of the enterocyte brush border to intestinal health and disease
肠上皮细胞刷状缘对肠道健康和疾病的贡献
- 批准号:
10651348 - 财政年份:2023
- 资助金额:
$ 33.43万 - 项目类别: